Speedy US review for MSD’s Keytruda in cervical cancer

14th March 2018 Uncategorised 0

US regulators will undertake a priority review of MSD’s Keytruda as a treatment for patients with advanced cervical cancer.

More: Speedy US review for MSD’s Keytruda in cervical cancer
Source: News